Calidi Biotherapeutics, Inc. (CLDI)
NYSE: CLDI · CIK 0001855485 · United States
Every official Calidi Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CLDI filings
Calidi Biotherapeutics, Inc. documents
- Calidi Biotherapeutics, Inc. 10-K 2026CLDI 10-K 2026: annual report for fiscal 2026
- Calidi Biotherapeutics, Inc. 10-K 2025CLDI 10-K 2025: annual report for fiscal 2025
- Calidi Biotherapeutics, Inc. 10-K 2024CLDI 10-K 2024: annual report for fiscal 2024
- Calidi Biotherapeutics, Inc. 10-K 2023CLDI 10-K 2023: annual report for fiscal 2023
- Calidi Biotherapeutics, Inc. 10-K 2022CLDI 10-K 2022: annual report for fiscal 2022
- Calidi Biotherapeutics, Inc. 10-Q 2026CLDI 10-Q 2026: quarterly report for fiscal 2026
- Calidi Biotherapeutics, Inc. 10-Q 2025CLDI 10-Q 2025: quarterly report for fiscal 2025
- Calidi Biotherapeutics, Inc. 10-Q 2024CLDI 10-Q 2024: quarterly report for fiscal 2024
- Calidi Biotherapeutics, Inc. 10-Q 2023CLDI 10-Q 2023: quarterly report for fiscal 2023
- Calidi Biotherapeutics, Inc. 10-Q 2022CLDI 10-Q 2022: quarterly report for fiscal 2022
- Calidi Biotherapeutics, Inc. 8-K 2026CLDI 8-K 2026: current report for fiscal 2026
- Calidi Biotherapeutics, Inc. 8-K 2025CLDI 8-K 2025: current report for fiscal 2025
- Calidi Biotherapeutics, Inc. 8-K 2024CLDI 8-K 2024: current report for fiscal 2024
- Calidi Biotherapeutics, Inc. 8-K 2023CLDI 8-K 2023: current report for fiscal 2023
- Calidi Biotherapeutics, Inc. 8-K 2022CLDI 8-K 2022: current report for fiscal 2022
- Calidi Biotherapeutics, Inc. DEF 14A 2026CLDI DEF 14A 2026: proxy statement for fiscal 2026
- Calidi Biotherapeutics, Inc. DEF 14A 2025CLDI DEF 14A 2025: proxy statement for fiscal 2025
- Calidi Biotherapeutics, Inc. DEF 14A 2024CLDI DEF 14A 2024: proxy statement for fiscal 2024
- Calidi Biotherapeutics, Inc. DEF 14A 2023CLDI DEF 14A 2023: proxy statement for fiscal 2023
- Calidi Biotherapeutics, Inc. DEF 14A 2022CLDI DEF 14A 2022: proxy statement for fiscal 2022
- Calidi Biotherapeutics, Inc. Form 4 2026CLDI Form 4 2026: insider trading filing for fiscal 2026
- Calidi Biotherapeutics, Inc. Form 4 2025CLDI Form 4 2025: insider trading filing for fiscal 2025
- Calidi Biotherapeutics, Inc. Form 4 2024CLDI Form 4 2024: insider trading filing for fiscal 2024
- Calidi Biotherapeutics, Inc. Form 4 2023CLDI Form 4 2023: insider trading filing for fiscal 2023
- Calidi Biotherapeutics, Inc. Form 4 2022CLDI Form 4 2022: insider trading filing for fiscal 2022
- Calidi Biotherapeutics, Inc. S-1 2026CLDI S-1 2026: registration statement for fiscal 2026
- Calidi Biotherapeutics, Inc. S-1 2025CLDI S-1 2025: registration statement for fiscal 2025
- Calidi Biotherapeutics, Inc. S-1 2024CLDI S-1 2024: registration statement for fiscal 2024
- Calidi Biotherapeutics, Inc. S-1 2023CLDI S-1 2023: registration statement for fiscal 2023
- Calidi Biotherapeutics, Inc. S-1 2022CLDI S-1 2022: registration statement for fiscal 2022
- Calidi Biotherapeutics, Inc. 13F 2026CLDI 13F 2026: institutional holdings for fiscal 2026
- Calidi Biotherapeutics, Inc. 13F 2025CLDI 13F 2025: institutional holdings for fiscal 2025
- Calidi Biotherapeutics, Inc. 13F 2024CLDI 13F 2024: institutional holdings for fiscal 2024
- Calidi Biotherapeutics, Inc. 13F 2023CLDI 13F 2023: institutional holdings for fiscal 2023
- Calidi Biotherapeutics, Inc. 13F 2022CLDI 13F 2022: institutional holdings for fiscal 2022
More companies